2 options
Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate / statement of Mary Denigan-Macauley.
- Format:
- Book
- Government document
- Author/Creator:
- United States. Government Accountability Office, author.
- Denigan-Macauley, Mary, author.
- Series:
- Testimony ; GAO-2-626T.
- Testimony ; GAO-20-626-T
- Language:
- English
- Subjects (All):
- United States. Food and Drug Administration--Rules and practice.
- United States.
- United States. Food and Drug Administration.
- COVID-19 (Disease)--Treatment--United States.
- COVID-19 (Disease).
- Drugs--Inspection--United States.
- Drugs.
- Drugs--United States--Safety measures--Evaluation.
- Pharmaceutical industry--Quality control--Evaluation.
- Pharmaceutical industry.
- Drugs--Safety regulations--United States--Evaluation.
- Drug reimportation--United States--Evaluation.
- Drug reimportation.
- Imports--United States--Safety measures--Evaluation.
- Imports.
- Drugs--Inspection.
- COVID-19 (Disease)--Treatment.
- Genre:
- Rules
- Physical Description:
- 1 online resource (26 pages) : color illustrations, color maps
- Place of Publication:
- [Washington, D.C.] : United States Government Accountability Office, 2020.
- Notes:
- "For release on delivery, expected at 2:30 p.m. ET, Tuesday, June 2, 2020."
- Includes bibliographical references.
- Online resource, PDF version; title from cover (GAO, viewed June 4, 2020).
- OCLC:
- 1156966114
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.